Mounjaro®
Starting from £179.99/mo
Start journey Learn moreCertain medicines interact with Mounjaro (tirzepatide) in ways that matter clinically. Because tirzepatide slows gastric emptying, it can alter how quickly your gut absorbs other drugs — which is relevant for anything where timing or blood-level consistency counts. This is a prescription-only medicine, so your prescriber will review your full medication list before treatment begins; the facts below explain what that review is actually looking for. The NHS tirzepatide page summarises the most significant interactions in plain terms alongside the prescribing guidance.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, and the honest answer is: yes, it can. Tirzepatide is a dual GIP and GLP-1 receptor agonist that slows gastric emptying as part of its mechanism. That delayed emptying means food and liquids move out of the stomach more slowly, and so do any oral medicines you take around the same time.
For many drugs this effect is modest and clinically unimportant. For others, where a predictable absorption profile matters, it is worth flagging. Medicines with narrow therapeutic windows (where the difference between a therapeutic dose and a toxic or ineffective one is small) are the ones that need the closest attention. Thyroid medicines (levothyroxine), certain anticoagulants, and some antiepileptics fall into this category. The practical advice is usually to separate the timing of these drugs from your Mounjaro injection day, or to be aware that blood-level monitoring may become more relevant once you start. Your prescriber or pharmacist can advise on specific timings for your situation.
You can read more about how tirzepatide works mechanically on our tirzepatide overview page, which covers the dual-receptor mechanism in more detail.
Two categories stand out in the prescribing guidance and are worth understanding before you start.
Diabetes medicines, insulin and sulfonylureas. If you take Mounjaro for weight management and you also have type 2 diabetes managed with insulin or a sulfonylurea (such as gliclazide or glimepiride), the combined glucose-lowering effect raises the risk of hypoglycaemia. Prescribers will generally reduce the dose of the other medicine before or shortly after starting tirzepatide. This is not a reason to avoid the combination; it is a reason to have it managed carefully.
Oral contraceptives. The MHRA advises that women taking an oral contraceptive pill alongside Mounjaro should use an additional, non-oral contraceptive method (condoms, for example) for the first four weeks of treatment and for four weeks after every dose increase. The concern is that slower gastric emptying may reduce the pill's absorption sufficiently to affect its reliability. No equivalent precaution currently applies to semaglutide. This advice is confirmed in NHS England's guidance on weight management injections.
For a full list of medicines that may not be suitable alongside tirzepatide, our detailed drug interaction page goes through the categories systematically.
There is no medicine that directly neutralises tirzepatide's mechanism in the way that, say, naloxone reverses opioids. The concern runs the other way: Mounjaro can affect other drugs, rather than other drugs reducing what Mounjaro does.
That said, a small number of situations require prescriber discussion before starting, and if you want a thorough overview of what medication you cannot take with Mounjaro, our dedicated page covers the key combinations and the reasons behind each concern. Certain immunosuppressants, ciclosporin in particular, have narrow therapeutic windows and monitoring schedules that may need to be adjusted once gastric-emptying is slowed. Corticosteroids (oral prednisolone, for example) can blunt glucose control and may complicate the expected response to tirzepatide in people with diabetes. These are not absolute contraindications, but they are items for clinical conversation.
Alcohol is not a pharmacological interaction in the strict sense, but it is worth noting: it can worsen nausea (already a common early side effect), destabilise blood sugar, and affect how reliably people stick to a reduced-calorie diet alongside treatment.
If you are thinking about the broader question of whether Mounjaro fits your medical picture, our page on who should not take Mounjaro covers contraindications and clinical cautions in full. The Mounjaro medicine page is also a good starting point if you want context on the licence and what treatment involves.
Every consultation at nume is reviewed personally by a GPhC-registered Independent Prescriber. Not a checklist-driven algorithm, a real clinician who reads your medical history, your current medication list, and any relevant conditions before making a decision. Interactions are one of the things that review is specifically designed to catch.
If you are already on a medicine that needs monitoring, our prescriber will either discuss adjustments with you, recommend that you speak to your GP first, or, where appropriate, coordinate a note to your GP in line with GPhC guidance. Transfer patients bringing a current dose from elsewhere are asked to provide evidence of that treatment, so the review covers continuity safely.
It is also worth knowing that the cost of the consultation is included, there is no separate fee. Our treatment page sets out what a complete course looks like, including what the single transparent price covers. For a broader look at the cost landscape, our page on the Eli Lilly price change gives useful market context without any obligation.
If you have a specific question before consulting, our FAQs page covers the most common ones, and our team is reachable via the contact page if you want to speak to someone directly. When you are ready, speak to our prescribers, the consultation is free and takes a few minutes to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.